Clinical Trials Browser

Phase 2 × Withdrawn × sintilimab × Clear all

NCT04625543 2022-04-26

Neoadjuvant Immunotherapy to ESCC

Phase 2 Withdrawn

Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT04398927 2021-02-04

Systemic Chemotherapy Plus PD-1 for Metastasis ICC

Phase 2 Withdrawn

Neoplasm Metastasis